Therefore, we hypothesize that rs2483205 may decrease CAD risk by modulating gene transcription and affecting TC levels, and it may be involved in adipogenesis by affecting PCSK9 levels, which enhances the risk of obesity. The gene discussed is PCSK9; the disease is coronary artery disorder.